ctrl K

Watchlist Price Alert

4D Molecular Therapeutics... (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

4.36

0.45 (11.51%)

At close: Jun 06, 2025, 3:59 PM

4.20

-3.56%

After-hours: Jun 06, 2025, 04:27 PM EDT

4D Molecular Therapeutics Revenue Breakdown

Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Collaboration And License Revenue Revenue	37K	20.01M	3.13M	18.04M	13.61M
Collaboration And License Revenue Revenue Growth	-99.82%	+539.44%	-82.65%	+32.52%	n/a

Revenue by Geography

Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
United States Revenue	37K	20.16M	35K	121K	-27K
United States Revenue Growth	-99.82%	+57488.57%	-71.07%	-548.15%	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Selling, General, and Administrative Revenue	12.94M	14.63M	12.65M	10.6M	8.7M	10.61M	9.11M	8.79M	7.99M	8.47M	8.05M	8.17M	8.23M	7.33M	8.19M	6.95M	5.54M	6.84M	3.68M	3.06M	3.65M	5.96M	3.05M	2.44M	2.44M	1.98M	1.98M	1.1M	1.1M
Selling, General, and Administrative Revenue Growth	-11.56%	+15.62%	+19.34%	+21.85%	-17.96%	+16.38%	+3.65%	+10.00%	-5.61%	+5.11%	-1.36%	-0.78%	+12.31%	-10.49%	+17.75%	+25.44%	-18.96%	+85.77%	+20.25%	-16.20%	-38.68%	+95.25%	+24.98%	0.00%	+23.05%	0.00%	+80.57%	0.00%	n/a
Research and Development Revenue	40.7M	43.09M	38.48M	31.86M	27.87M	26.03M	25.07M	23.58M	22.41M	21.5M	18.94M	20.42M	19.38M	17.53M	15.84M	15.22M	12.77M	12.61M	11.55M	15.72M	13.16M	12.36M	9.37M	8.49M	8.49M	5.08M	5.08M	4.1M	4.1M
Research and Development Revenue Growth	-5.54%	+11.96%	+20.79%	+14.32%	+7.08%	+3.84%	+6.28%	+5.23%	+4.24%	+13.52%	-7.26%	+5.37%	+10.57%	+10.66%	+4.05%	+19.22%	+1.30%	+9.09%	-26.49%	+19.47%	+6.46%	+31.84%	+10.38%	0.00%	+67.27%	0.00%	+23.71%	0.00%	n/a